J.P. Morgan

Life science and biotech remain strong. That’s according to Peter Meath, J.P. Morgan’s managing director industry head of Life Sciences. “Broadly, it’s a very positive sentiment these days, even given some 4Q volatility,” he told WRAL TechWire.